Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Double-blind Randomised Controlled Trial Studying the Effect of Sotagliflozin Versus Placebo in Individuals With Heart Failure and Type 1 Diabetes.

NCT06435156 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT06435156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Double-blind Randomised Controlled Trial Studying the Effect of Sotagliflozin Versus Placebo in Individuals With Heart Failure and Type 1 Diabetes.
Lead sponsor
University of Dundee
Phase
Phase 2
Overall status
Recruiting
Start date
January 28, 2025
Completion date
October 31, 2027
Enrollment
320 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, type 1 diabetes